Topics

FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk

14:00 EST 15 Jan 2020 | Drugs.com

WEDNESDAY, Jan. 15, 2020 -- The prescription weight control medicine lorcaserin (Belviq, Belviq XR) may increase the risk for cancer, according to the results of a clinical trial assessing the safety of the drug, the U.S. Food and Drug...

Original Article: FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk

NEXT ARTICLE

More From BioPortfolio on "FDA: Weight Control Drug Lorcaserin May Raise Cancer Risk"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...